首页> 美国卫生研究院文献>Frontiers in Systems Neuroscience >Striatal Cholinergic Interneurons in a Knock-in Mouse Model of L-DOPA-Responsive Dystonia
【2h】

Striatal Cholinergic Interneurons in a Knock-in Mouse Model of L-DOPA-Responsive Dystonia

机译:纹状胆碱能中间神经元在L-DOPA反应性肌张力障碍的敲入小鼠模型中。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Striatal cholinergic dysfunction is a common phenotype associated with various forms of dystonia in which anti-cholinergic drugs have some therapeutic benefits. However, the underlying substrate of striatal cholinergic defects in dystonia remain poorly understood. In this study, we used a recently developed knock-in mouse model of dopamine-responsive dystonia (DRD) with strong symptomatic responses to anti-cholinergic drugs, to assess changes in the prevalence and morphology of striatal cholinergic interneurons (ChIs) in a model of generalized dystonia. Unbiased stereological neuronal counts and Sholl analysis were used to address these issues. To determine the potential effect of aging on the number of ChIs, both young (3 months old) and aged (15 months old) mice were used. For purpose of comparisons with ChIs, the number of GABAergic parvalbumin (PV)-immunoreactive striatal interneurons was also quantified in young mice. Overall, no significant change in the prevalence of ChIs and PV-immunoreactive cells was found throughout various functional regions of the striatum in young DRD mice. Similar results were found for ChIs in aged animals. Subtle changes in the extent and complexity of the dendritic tree of ChIs were found in middle and caudal regions of the striatum in DRD mice. Additional immunohistochemical data also suggested lack of significant change in the expression of striatal cholinergic M1 and M4 muscarinic receptors immunoreactivity in DRD mice. Thus, together with our previous data from a knock-in mouse model of DYT-1 dystonia (Song et al., ), our data further suggest that the dysregulation of striatal cholinergic transmission in dystonia is not associated with major neuroplastic changes in the morphology or prevalence of striatal ChIs.>Highlights class="simple" style="list-style-type:none">
  • -There is no significant change in the number of striatal ChIs in young and aged mice model of DRD
  • -There is no significant change in the prevalence of striatal GABAergic PV-containing interneurons in the striatum of young mice models of DRD
  • -Subtle morphological changes in the dendritic arborization of striatal ChIs are found in the middle and caudal tiers of the striatum in young mice models of DRD
  • -The levels of both M1 and M4 muscarinic receptors immunoreactivity are not significantly changed in the striatum of DRD mice
  • -Major changes in the prevalence and morphology of striatal ChIs are unlikely to underlie striatal cholinergic dysfunction in DRD
  • 机译:纹状体胆碱能功能障碍是与各种形式的肌张力障碍有关的常见表型,其中抗胆碱能药物具有某些治疗益处。然而,肌张力障碍中纹状体胆碱能缺陷的潜在底物仍然知之甚少。在这项研究中,我们使用了最近开发的对多巴胺反应性肌张力障碍(DRD)具有强烈抗症状的抗胆碱药症状的敲入小鼠模型,以评估模型中纹状体胆碱能中间神经元(ChIs)的患病率和形态变化的肌张力障碍。使用无偏见的立体神经元计数和Sholl分析来解决这些问题。为了确定衰老对ChIs数量的潜在影响,使用了年轻(3个月大)和年龄大(15个月大)小鼠。为了与ChIs进行比较,还对年轻小鼠中的GABA能小白蛋白(PV)免疫反应性纹状体中间神经元进行了定量。总体而言,在年轻的DRD小鼠的整个纹状体各个功能区域中,未发现ChIs和PV免疫反应性细胞的患病率有显着变化。在老年动物中发现ChIs的结果相似。在DRD小鼠的纹状体中部和尾部发现了ChIs树突状树的程度和复杂性的细微变化。其他免疫组织化学数据也表明,在DRD小鼠中纹状体胆碱能M1和M4毒蕈碱受体的表达没有明显变化。因此,再加上我们先前从DYT-1肌张力障碍的敲入小鼠模型获得的数据(Song等,),我们的数据进一步表明肌张力障碍中纹状体胆碱能传递的失调与形态学上的主要神经增塑改变无关>亮点。 class =“ simple” style =“ list-style-type:none”> <!-list-behavior = simple prefix-word = mark-type = none max-label-size = 1->
  • -DRD的成年和老年小鼠模型的纹状ChI数量没有显着变化
  • -DRD幼鼠模型的纹状体中纹状体含有GABA能PV的中间神经元的发生率无显着变化
  • -纹状体ChIs树突状乔化的细微形态变化是在DRD幼鼠模型的纹状体中部和尾部发现
  • -M1和M4毒蕈碱受体的免疫水平DRD小鼠的纹状体中的反应性没有明显改变
  • -纹状体ChIs的患病率和形态的重大变化不太可能是DRD的纹状体胆碱能功能障碍的基础
  • 著录项

    相似文献

    • 外文文献
    • 中文文献
    • 专利
    代理获取

    客服邮箱:kefu@zhangqiaokeyan.com

    京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
    • 客服微信

    • 服务号